Screener
G&A at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest | 28,409 | 27,100 |
| Triple-net portfolio operating expenses | 3,773 | 3,479 |
| Senior housing - managed portfolio operating expenses | 81,869 | 56,454 |
| General and administrative | 14,862 | 12,728 |
| Recovery of loan losses | (213) | (173) |
| Impairment of real estate | 440 | — |
| Total expenses | 182,271 | 143,082 |
| Other (expense) income | (55) | 38 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's G&A?
- Sabra Healthcare (SBRA) reported G&A of $14.86M in Q1 2026.
- How has Sabra Healthcare's G&A changed year-over-year?
- Sabra Healthcare's G&A increased by 16.8% year-over-year, from $12.73M to $14.86M.
- What is the long-term trend for Sabra Healthcare's G&A?
- Over 4 years (2021 to 2025), Sabra Healthcare's G&A has grown at a 11.6% compound annual growth rate (CAGR), from $34.67M to $53.71M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about Sabra Healthcare's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude